HAVCR1 and COVID-19: KIM-1 was elevated in COVID-19 (+) AKIN 0 cases compared with the COVID (−) AKIN 0 historical cohort (uKIM-1: 2.57 ± 2.44 in COVID-19 [+] vs. 1.96 ± 2.51 ng/ml in COVID-19 [−], P < 0.01; Supplementary Figure S4).